Sodium-Glucose Cotransporter 2 Inhibitors in the Treatment of Type 2 Diabetes: ADO - Lupine Publishers

Sodium-Glucose Cotransporter 2 Inhibitors in the Treatment of Type 2 Diabetes by Nikolaos Papanas in Archives of Diabetes & Obesity in Lupine Publishers

Over the past years, type 2 diabetes mellitus (T2DM) has become a global pandemic, both in developed and developing countries [1,2]. Its aetiology is multifactorial, including genetic factors, increasing age, obesity and insulin resistance [3]. Among these factors, obesity is of paramount importance, and its management can be of benefit [4,5].

https://www.lupinepublishers.com/diabetes-obesity-journal/abstracts/ADO.MS.ID.000111.php

https://www.lupinepublishers.com/diabetes-obesity-journal/fulltext/ADO.MS.ID.000111.php

https://www.lupinepublishers.com/diabetes-obesity-journal/pdf/ADO.MS.ID.000111.pdf